Search filters

List of works by Elliott D. Kieff

A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation

scientific article published on 25 April 2013

A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes

scientific article published on April 1987

A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes

scientific article published on April 1988

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

scientific article published on November 1, 1984

A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes

scientific article

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

scientific article published on May 1990

A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant

scientific article published on May 1, 1992

A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes

scientific article published on June 1988

A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus

scientific article published on September 1985

An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200)

scientific article published on February 1984

An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator

scientific article published on November 1991

An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase

scientific article published on July 1991

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation

scientific article

An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases

scientific article published on August 1, 1992

An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes

scientific article published on July 1987

An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro

scientific article published on March 1994

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking

scientific article

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

scientific article published on December 1996

BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication

scientific article published on November 1, 1991

Biochemistry of Epstein—Barr Virus

Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation

scientific article published on 4 May 2011

Cephalexin-Related Nephropathy

scientific article (publication date: 10 November 1975)

Characterization of an Epstein-Barr virus receptor on human epithelial cells

scientific article

Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro

scientific article published on April 1, 1983

Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein

scientific article

Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio.

scientific article

Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.

scientific article

Comparative studies of Epstein-barr virus strains from Ghana and the United States

scientific article published on January 15, 1976

Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing

scientific article published on 11 March 2016

Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro

scientific article published on 17 August 2006

DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group

scientific article published on March 1, 1982

Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family

scientific article published on August 1986

Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.

scientific article published on August 1993

Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression

scientific article published on December 1, 1991

Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation

scholarly article

Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

scientific article published on March 1989

EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes

scientific article published in June 1996

EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines

scientific article published on October 2006

EBNA-LP associates with cellular proteins including DNA-PK and HA95.

scientific article

EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth

scientific article

EBNA3C coactivation with EBNA2 requires a SUMO homology domain

scientific article

EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding

scientific article published on April 25, 2011

Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40

scientific article (publication date: 4 May 2001)

Effects of virally expressed interleukin-10 on vaccinia virus infection in mice.

scientific article

Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2

scientific article published on January 1, 2002

Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth

scientific article published on October 2003

Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419

scientific article published on October 5, 2010

Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.

scholarly article

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells

scientific article published on April 1, 1991

Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants

scientific article published on August 1, 1992

Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication

scientific article

Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion

scientific article published on September 1, 1982

Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells

scientific article

Epstein-Barr virus DNA. X. Direct repeat within the internal direct repeat of Epstein-Barr virus DNA

scientific article published on November 1, 1981

Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation

scientific article published in January 1997

Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line

scientific article

Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line

scientific article published on November 1, 1980

Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells

scientific article published on May 1, 1981

Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells

scientific article published on July 1, 1982

Epstein-Barr virus and virus human protein interaction maps

scientific article

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth

scientific article

Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

scientific article published on February 1987

Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein

scientific article

Epstein-Barr virus latent genes

scientific article

Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation

scientific article

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity

scientific article published on November 1988

Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines

scientific article published on September 1989

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

scientific article published on May 1990

Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.

scientific article

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

scientific article published on October 1993

Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes

scientific article published on June 1, 1993

Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin

scientific article published on September 1989

Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors

scholarly article

Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice

scientific journal article

Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice

scientific article

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

scientific article

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

scientific article published on July 1990

Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes

scientific article

Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.

scientific article published on 16 December 2013

Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines

scientific article

Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

scientific article published on 28 October 2013

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression

scientific article

Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association

scientific article

Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter

scientific article published on January 2000

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

scientific article

Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation

scientific article published on May 1, 1991

Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element

scientific article published on August 1, 1991

Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.

scientific article published in January 1995

Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical

scientific article

Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

scientific article published on 23 September 2009

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa

scientific article published in May 1995

Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation

scientific article published on September 1, 1997

Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.

scientific article published on April 1993

Epstein-Barr virus oncoprotein super-enhancers control B cell growth

scientific article

Epstein-Barr virus recombinants from overlapping cosmid fragments

scientific article published on December 1993

Epstein-Barr virus recombinants with specifically mutated BCRF1 genes

scientific article published on December 1, 1993

Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation

scientific article

Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes

scientific article published on September 1990

Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes

scientific article published on August 1, 1992

Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors

scientific article

Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

scientific article published on October 1988

Epstein-Barr virus: Structure of the viral DNA and analysis of viral RNA in infected cells

scientific article published on November 30, 1979

Epstein-barr virus-induced changes in B-lymphocyte gene expression

scientific article

Epstein–Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth

scientific article published on December 4, 2001

Epstein–Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; Only the NTD interaction is essential for lymphoblastoid cell growth

scientific article published on March 26, 2011

Epstein–Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin

scientific article published on October 28, 1997

Epstein–Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ

scientific article published on August 18, 1998

Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer

scientific article published on October 1, 1984

Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells

scientific article published on November 1, 1991

Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.

scientific article published on February 1999

Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells

scientific article published on June 1987

Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells

scientific article published on August 1986

Four EBNA2 domains are important for EBNALP coactivation

scientific article published on October 2004

Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines

scientific article

Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells

scientific article published on July 7, 2011

Genome-wide siRNA screen for mediators of NF-κB activation

scientific article published on 17 January 2012

Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA

scientific article published on February 1, 1981

Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2

scientific article published on 6 March 2007

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses

scientific article published on April 1990

Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-kappaB

scientific article

IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation

scholarly article

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

scholarly article

Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen

scientific article published on December 1, 1984

Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA

scientific article published on December 1, 1982

Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

scientific article

Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies

scientific article published on July 1, 1983

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

scientific article published on July 1, 1992

Identification of the Epstein-Barr virus gp85 gene

scientific article published on April 1988

Identification, cloning and characterization of a novel nuclear protein, HA95, homologous to A-kinase anchoring protein 95

scientific article

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins

scientific journal article

Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-jkappa in human B and T cells

scientific article (publication date: 2000)

Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110

scientific article published on April 1990

LMP1 TRAFficking activates growth and survival pathways

scientific article published on January 2007

LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation

scientific article

LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB

scientific article

Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells

scientific article published on August 11, 2011

Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling

scientific article

Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection

scientific article published on April 1986

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

scientific article

Long internal direct repeat in Epstein-Barr virus DNA

scientific article published on October 1, 1982

Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB

scientific article

Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.

scholarly article

Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection

scientific article

Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation

scientific article published on January 1993

Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100

scientific article

Modulation of Epstein–Barr Virus Nuclear Antigen 2-dependent transcription by protein arginine methyltransferase 5

scientific article published on December 19, 2012

Molecular basis for Epstein-Barr virus induced pathogenesis and disease

scientific article published on January 1, 1991

Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease

scientific article published on 28 March 2017

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

scientific article

NF-κB Inhibition in EBV-Transformed Lymphoblastoid Cell Lines

scientific article published on January 1, 2002

NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression

scientific article

Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis

scientific article

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells

scientific article

Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells

scientific article

Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription

scientific article published on 16 December 2013

Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein

scientific article published on August 1, 1984

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site

scientific article published on July 1986

Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription

scientific article (publication date: 25 April 1997)

One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain

scientific article published on September 1, 1983

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

scientific article published on April 1986

Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells

scientific article published on July 1, 1992

Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity

scientific article (publication date: 15 March 2005)

Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins

scientific article

Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation

scientific journal article

Proteins of purified Epstein-Barr virus

scholarly article

RETRACTION: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation

retraction notice

RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells

scientific article published on May 1, 1983

RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines

scholarly article

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

scientific article

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro

scientific article published on February 1991

Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.

scientific article published in February 1995

Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes

scientific article published on October 1, 1982

Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat

scientific article

Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.

scientific article

Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site

scientific article published on July 1991

Retracted: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation

retracted paper

Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function

scientific article published on 8 February 2016

Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation

scientific article

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

scientific article published on April 2004

Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP.

scientific article published on May 1999

Role of the TRAF Binding Site and NF-κB Activation in Epstein-Barr Virus Latent Membrane Protein 1-Induced Cell Gene Expression

scientific article published on October 1, 1998

Roscovitine Inhibits EBNA1 Serine 393 Phosphorylation, Nuclear Localization, Transcription, and Episome Maintenance

scientific article published on January 5, 2011

Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection

scientific article published on February 1, 1992

Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections

scientific article published on October 1, 1982

Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization

scientific article published on 23 June 2012

Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome

scientific article published on 31 January 2014

Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.

scientific article published on December 1988

The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2

scientific article

The Clinical Research Forum and Association of American Physicians disagree with criticism of the NIH Roadmap

scientific article published on August 2006

The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.

scientific article published on October 1994

The Epstein-Barr Virus Latent Membrane Protein 1 Putative Janus Kinase 3 (JAK3) Binding Domain Does Not Mediate JAK3 Association or Activation in B-Lymphoma or Lymphoblastoid Cell Lines

scientific article published on January 1, 2002

The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE

scientific article published on September 1, 1995

The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle

scientific article published on December 1, 1992

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

scientific article published in February 1995

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

scientific article published on August 1994

The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73.

scientific article published on December 1995

The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.

scientific article published in January 1995

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

scientific article published on December 1, 1991

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

scientific article

The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation.

scientific article published in April 1996

The NF-κB genomic landscape in lymphoblastoid B cells

scientific article

The Nuclear Chaperone Nucleophosmin Escorts an Epstein-Barr Virus Nuclear Antigen to Establish Transcriptional Cascades for Latent Infection in Human B Cells

scientific article published on December 13, 2012

The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B

scientific article

The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)

scientific article

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

scientific article published on 10 February 2009

The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.

scientific article published on April 1993

The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential

scientific article published on November 1, 1992

The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation

scientific article published on December 1999

The structural basis for the recognition of diverse receptor sequences by TRAF2

scientific article

The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts

scientific article published on July 1988

Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes

scientific article published on April 1990

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

scientific article

Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene

scientific article published on June 1985

Two related Epstein-Barr virus membrane proteins are encoded by separate genes

scientific article published on February 1989

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

scientific article published on December 1, 1984

Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro

scientific article published on May 1, 1992

Viral perturbations of host networks reflect disease etiology

scientific article

Virus and cell RNAs expressed during Epstein-Barr virus replication

scientific article

cis -Acting Effects on RNA Processing and Drosha Cleavage Prevent Epstein-Barr Virus Latency III BHRF1 Expression

scientific article published on June 22, 2011

cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site

scientific article published on April 1990